Tim Breen

Publications by Year

Research Areas

Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Ovarian cancer diagnosis and treatment, Lung Cancer Research Studies, Avian ecology and behavior

Most-Cited Works

• → Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology(2008)493 cited
• → Use of Reperfusion Therapy for Acute Myocardial Infarction in the United States(1998)318 cited
• → Activity of 2 methoxyestradiol (Panzem® NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trial(2009)102 cited
• → Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum‐resistant ovarian cancer and primary peritoneal carcinomatosis(2008)75 cited
• → COMPARATIVE FECUNDITY AND SURVIVAL OF BALD EAGLES FLEDGED FROM SUBURBAN AND RURAL NATAL AREAS IN FLORIDA(2004)73 cited
• → Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)(2018)43 cited
• → Analysis of professional competencies for the clinical research data management profession: implications for training and professional certification(2017)27 cited
• → Gefitinib Plus Celecoxib in Chemotherapy-Naïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: A Phase II Study from the Hoosier Oncology Group(2008)23 cited
• → Phase II trial of consolidation Pembrolizumab following concurrent chemoradiation in patients (pts) with unresectable or inoperable stage III non-small cell lung cancer (NSCLC): initial safety data from HCRN LUN 14-179.(2016)7 cited
• → B5-01: Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023(2007)7 cited